NEW YORK ( TheStreet) -- Several stocks trading near $5 were moving on above-average volume during Friday's session.

Curis ( CRIS) dropped by 59 cents, or 19.9%, to $2.37 after the drug company priced a registered direct offering of 6.45 million units at a price of $2.52 a unit for gross proceeds of $15.26 million before fees and expenses. Each unit consists of one share of common stock and a warrant to buy 0.25 of a share at an exercise price of $3.55 per share. Volume topped 1.81 million shares, compared to the 50-day average daily volume of 409,000, according to the Nasdaq.

IsoRay ( ISR) declined by 36 cents, or 22.8%, to $1.22, retracing some of Thursday's 92% rally. On Thursday, after the company announced that a patient with colorectal cancer tolerated the first Cesium-131(Cs-131) implant well and had no evidence of cancer recurrence or any side effects that can be attributed to the implant at the last follow-up visit. Volume topped 1.34 million shares, compared to the three-month average daily volume of 229,000, according to Yahoo! Finance.

Lodgian ( LGN) jumped by 67 cents, or 38%, to $2.45 after an affiliate of Lone Star Funds agreed to acquire the hotel operator for $2.50 in an all-cash deal worth $270 million. Volume topped 979,000 shares, compared to the three-month average daily volume of 18,000.

PharmAthene ( PIP) rallied by 15 cents, or 8.7%, to $1.88 in the absence of any company-specific news Friday. Earlier this month, the biodefense company said that the Biomedical Advance Research and Development Authority, or BARDA, has intentions to negotiate a contract modification for continued development of its recombinant protective rPA anthrax vaccine candidate, SparVax. PharmAthene said that it would submit a proposal to BARDA by Feb. 1 for funding to advance the rPA vaccine program to the stage of a procurement solicitation. Volume topped 1.66 million shares, compared to the three-month average daily volume of 629,000.

-- Written by Robert Holmes in Boston.

Check out all of Friday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

If you liked this article you might like

Paradigm Opportunity Protects Investors in Tough Times

Paradigm Opportunity Protects Investors in Tough Times

5 Things You Need to Know Before the Stock Market Opens (Correct)

5 Things You Need to Know Before the Stock Market Opens (Correct)

U.S. Investors Brace for a Third Bailout in Greece

U.S. Investors Brace for a Third Bailout in Greece

5 Things You Need to Know Before the Stock Market Opens

5 Things You Need to Know Before the Stock Market Opens

40 Hedge Funds' Best Stocks Show the Way for 2012 (Update 1)

40 Hedge Funds' Best Stocks Show the Way for 2012 (Update 1)